KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2026)

Hims & Hers Health's EBITDA Margin history spans 7 years, with the latest figure at 16.25% for Q1 2026.

  • On a quarterly basis, EBITDA Margin fell 2472.0% to 16.25% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.74%, a 995.0% decrease, with the full-year FY2025 number at 5.58%, down 294.0% from a year prior.
  • EBITDA Margin hit 16.25% in Q1 2026 for Hims & Hers Health, down from 3.56% in the prior quarter.
  • Over the last five years, EBITDA Margin for HIMS hit a ceiling of 18.92% in Q3 2024 and a floor of 17.46% in Q2 2022.
  • Historically, EBITDA Margin has averaged 1.51% across 5 years, with a median of 0.51% in 2023.
  • Biggest five-year swings in EBITDA Margin: soared 8215bps in 2022 and later crashed -2472bps in 2026.
  • Tracing HIMS's EBITDA Margin over 5 years: stood at 6.41% in 2022, then skyrocketed by 108bps to 0.51% in 2023, then surged by 941bps to 5.29% in 2024, then tumbled by -33bps to 3.56% in 2025, then crashed by -557bps to 16.25% in 2026.
  • Business Quant data shows EBITDA Margin for HIMS at 16.25% in Q1 2026, 3.56% in Q4 2025, and 2.65% in Q3 2025.